Baraniuk James N
Georgetown University, Washington, DC 20007-2197, USA.
Curr Allergy Asthma Rep. 2009 Mar;9(2):149-52. doi: 10.1007/s11882-009-0022-5.
Many common treatments for rhinitis symptoms are inadequate or ineffective. This may be in part because the drug does not address the pathologically altered mechanism of the rhinopathy. Objective measures may not detect treatment effects, or the treatment end points may be only subjective in nature. In many cases, these issues have not arisen because of potent placebo effects. Understanding the psychological, pharmacologic, and physiologic components of placebos is important for separating true treatment effects from those of the excipients in the vehicle. Separating the wasteful and potentially harmful effects of those excipients from the harmless and often partially beneficial effects on temporary symptom control is an important issue in clinical pharmacology that can aid in effective clinical trial design, use of objective and subjective test measures, and development of drugs to treat rhinitis.
许多针对鼻炎症状的常见治疗方法并不充分或无效。这可能部分是因为药物未能解决鼻病发生病理改变的机制。客观指标可能无法检测到治疗效果,或者治疗终点可能本质上只是主观的。在许多情况下,这些问题并非由于强大的安慰剂效应而出现。了解安慰剂的心理、药理和生理成分对于区分真正的治疗效果与载体中辅料的效果很重要。将这些辅料的浪费性和潜在有害影响与对临时症状控制的无害且往往部分有益的影响区分开来,是临床药理学中的一个重要问题,有助于进行有效的临床试验设计、使用客观和主观测试指标以及开发治疗鼻炎的药物。